Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000232696 | SCV000290424 | benign | Primary ciliary dyskinesia 23 | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001668397 | SCV001882692 | benign | not provided | 2021-01-19 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000232696 | SCV002506042 | benign | Primary ciliary dyskinesia 23 | 2022-10-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002461009 | SCV002755031 | benign | Primary ciliary dyskinesia | 2016-07-08 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001668397 | SCV005316449 | benign | not provided | criteria provided, single submitter | not provided |